Evoke Pharma Operating Expenses 2012-2024 | EVOK
Evoke Pharma operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Evoke Pharma Annual Operating Expenses
(Millions of US $) |
| 2023 |
$13 |
| 2022 |
$10 |
| 2021 |
$10 |
| 2020 |
$13 |
| 2019 |
$7 |
| 2018 |
$8 |
| 2017 |
$11 |
| 2016 |
$11 |
| 2015 |
$12 |
| 2014 |
$13 |
| 2013 |
$3 |
| 2012 |
$2 |
| 2011 |
$2 |
Evoke Pharma Quarterly Operating Expenses
(Millions of US $) |
| 2024-09-30 |
$4 |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$4 |
| 2023-09-30 |
$3 |
| 2023-06-30 |
$3 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$3 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$3 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$3 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$2 |
| 2020-06-30 |
$7 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$1 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$2 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$2 |
| 2018-03-31 |
$2 |
| 2017-12-31 |
$3 |
| 2017-09-30 |
$4 |
| 2017-06-30 |
$3 |
| 2017-03-31 |
$2 |
| 2016-12-31 |
$2 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$3 |
| 2016-03-31 |
$3 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$3 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$3 |
| 2014-09-30 |
$4 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$2 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-09-30 |
$0 |
| 2012-06-30 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
